Stay updated with breaking news from Phillip Sharp. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
NEW YORK — Shares of Biogen surged on Wednesday following a report that South Korean giant Samsung Group is in talks to acquire the US biotech company for more than $40 billion.Biogen, which is known for its Alzheimer's drug Aduhelm and a neurology-focused medication pipeline, approached Samsung on a potential deal that could be valued at more than $42 billion, according to a
NEW YORK — Shares of Biogen surged on Wednesday following a report that South Korean giant Samsung Group is in talks to acquire the US biotech company for more than $40 billion.Biogen, which is known for its Alzheimer's drug Aduhelm and a neurology-focused medication pipeline, approached Samsung on a potential deal that could be valued at more than $42 billion, according to a
Shares of Biogen surged Wednesday following a report that South Korean giant Samsung Group is in talks to acquire the US biotech company
NEW YORK, Dec 30 — Shares of Biogen surged Wednesday following a report that South Korean giant Samsung Group is in talks to acquire the US biotech company for more than US$40 billion (RM167.3 billion). Biogen, which is known for its Alzheimer’s drug Aduhelm and a neurology-focused medication...
NEW YORK - Shares of Biogen surged Wednesday following a report that South Korean giant Samsung Group is in talks to acquire the US biotech company for more than $40 billion.